Safety and Side Effects GHK-Cu has one of the best safety profiles in the peptide category
261, 262 Although high rates of efficacy were reported (47 to 64%), given the extremely small combined sample size of fewer than 30 patients, the relatively serious AEs (e.g., new diabetes onset, exacerbation of existing diabetes, pneumonia with septic shock, increased blood pressure), and the known risks of systemic long-term glucorticoid use, risks/burdens clearly outweigh benefits and the Panel recommends that this therapy not be used long-term
The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist all available to CCO Members
Vascular recruitment the organised attraction of new blood vessel ingrowth into healing tissue is considered a central mechanism across BPC-157s cross-tissue cytoprotective effects and is described as a defining feature distinguishing it from other growth factors in the healing biology literature